LP-261
LP-261 is a potent and orally active anti-mitotic agent and shows an inhibition of in vitro tubulin polymerization with an EC50 of 3.2 μM[1]. LP-261 inhibits growth of a human non-small-cell lung tumor (NCI-H522) in vivo and can be used for cancer research[1].
Product Specifications
CAS Number
915412-67-8
UNSPSC
12352005
Target
Microtubule/Tubulin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lp-261.html
Purity
99.94
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
CS(=O)(NC1=CC(C(C2=CC(OC)=NC=C2)=O)=CC(C3=CC=CC4=C3C=CN4)=C1)=O
Molecular Formula
C22H19N3O4S
Molecular Weight
421.47
References & Citations
[1]Rupa S Shetty, et al. Synthesis and pharmacological evaluation of N- (3- (1H-indol-4-yl) -5- (2-methoxyisonicotinoyl) phenyl) methanesulfonamide (LP-261), a potent antimitotic agent. J Med Chem. 2011 Jan 13;54 (1) :179-200
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM040571 100 µg
Recombinant Mouse CD200R4/CD200RLa Protein (His Tag)
Sign In for Pricing
View Details